Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companies Response To Thrombosis Data Differs; New Definition Unveiled

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific and Johnson & Johnson/Cordis had markedly different responses to analyses reported last week at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. showing an increased risk of thrombosis from use of their drug-eluting stents (DES)

You may also be interested in...



FDA Previews New Drug-Eluting-Stent Guidance At CRT Meeting In D.C.

FDA's upcoming drug-eluting-stent guidance will emphasize long-term safety and shift the focus of trials from surrogate to clinical endpoints

FDA Previews New Drug-Eluting-Stent Guidance At CRT Meeting In D.C.

FDA's upcoming drug-eluting-stent guidance will emphasize long-term safety and shift the focus of trials from surrogate to clinical endpoints

NEJM Articles Fuel Debate On Drug-Eluting-Stent Safety

Results of a Swedish registry of almost 20,000 patients, published in the New England Journal of Medicine, are adding fuel to the ongoing debate on drug-eluting-stent safety

Related Content

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel